Inga Odenholt

Inga Odenholt

UNVERIFIED PROFILE

Are you Inga Odenholt?   Register this Author

Register author
Inga Odenholt

Inga Odenholt

Publications by authors named "Inga Odenholt"

Are you Inga Odenholt?   Register this Author

51Publications

-Reads

Considerable variation of trough β-lactam concentrations in older adults hospitalized with infection-a prospective observational study.

Eur J Clin Microbiol Infect Dis 2018 Mar 29;37(3):485-493. Epub 2018 Jan 29.

Clinical Infection Medicine, Department of Translational Medicine, Lund University, Rut Lundskogs gata 3, plan 6, SE20502, Malmö, Sweden.

View Article
March 2018

Assessment of early combination effects of colistin and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii in dynamic time-kill experiments.

Infect Dis (Lond) 2017 Jul 6;49(7):521-527. Epub 2017 Mar 6.

a Department of Medical Sciences , Uppsala University , Uppsala , Sweden.

View Article
July 2017

Prevalence of penicillin-non-susceptible Streptococcus pneumoniae in children in day-care centres subjected to an intervention to prevent dispersion.

Infect Dis (Lond) 2015 May 6;47(5):338-44. Epub 2015 Mar 6.

From the Infectious Disease Unit, Department of Clinical Sciences, Lund University , Malmö , Sweden.

View Article
May 2015

Risk factors, outcome and impact of empirical antimicrobial treatment in extended-spectrum β-lactamase-producing Escherichia coli bacteraemia.

Scand J Infect Dis 2014 Nov 8;46(11):753-62. Epub 2014 Sep 8.

From the Faculty of Medicine, Lund University , Malmö , Sweden.

View Article
November 2014

Risk factors for pneumococcal carriage in day care centers: a retrospective study during a 10-year period.

Pediatr Infect Dis J 2014 May;33(5):536-8

From the *Infectious Disease Unit, Department of Clinical Sciences, Skåne University Hospital, Malmö; †Medical Microbiology, Department of Laboratory Medicine, Lund University, Malmö; ‡Department of Infection Control, Laboratory Medicine; and §Regional Office of Communicable Disease Control and Prevention, Region Skåne, Sweden.

View Article
May 2014

Risk factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli in a county of Southern Sweden.

Infect Drug Resist 2013 19;6:93-7. Epub 2013 Sep 19.

Infectious Diseases Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden.

View Article
October 2013

High incidence of septic shock caused by Streptococcus pneumoniae serotype 3--a retrospective epidemiological study.

BMC Infect Dis 2013 Oct 22;13:492. Epub 2013 Oct 22.

Department of Laboratory Medicine Malmö, Medical microbiology, SE-205 02 Malmö, Sweden.

View Article
October 2013

Eradication of nasopharyngeal carriage of penicillin-non-susceptible Streptococcus pneumoniae--is it possible?

Scand J Infect Dis 2012 Dec 19;44(12):909-14. Epub 2012 Sep 19.

Infectious Diseases Unit, Department of Clinical Sciences, Malmö, Sweden.

View Article
December 2012

Prevalence of extended-spectrum beta-lactamase-producing bacteria in food.

Infect Drug Resist 2012 16;5:143-7. Epub 2012 Oct 16.

Infectious Diseases Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden.

View Article
October 2012

Duration of colonization with extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea.

Scand J Infect Dis 2012 Aug 31;44(8):573-7. Epub 2012 Jan 31.

Infectious Diseases Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden.

View Article
August 2012

Increase of β-lactam-resistant invasive Haemophilus influenzae in Sweden, 1997 to 2010.

Antimicrob Agents Chemother 2012 Aug 11;56(8):4408-15. Epub 2012 Jun 11.

Medical Microbiology, Department of Laboratory Medicine Malmö, Lund University, Sweden.

View Article
August 2012

Necrotizing myositis and septic shock caused by Haemophilus influenzae type f in a previously healthy man diagnosed with an IgG3 and a mannose-binding lectin deficiency.

Scand J Infect Dis 2011 Dec 5;43(11-12):972-6. Epub 2011 Jul 5.

Medical Microbiology, Department of Laboratory Medicine Malmö, Lund University, Skåne University Hospital, SE-20502 Malmö, Sweden.

View Article
December 2011

Duration of methicillin-resistant Staphylococcus aureus colonization after diagnosis: a four-year experience from southern Sweden.

Scand J Infect Dis 2011 Jul 2;43(6-7):456-62. Epub 2011 Mar 2.

Department of Infectious Diseases Helsingborg Hospital, Helsingborg, Sweden.

View Article
July 2011

Bacterial aetiology in ventilator-associated pneumonia at a Swedish university hospital.

Scand J Infect Dis 2010 Jul;42(6-7):469-74

Department of Clinical Sciences, Malmö, Lund University, Sweden.

View Article
July 2010

Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea.

Scand J Infect Dis 2010 Apr;42(4):275-80

Department of Clinical Sciences, Lund University, Malmö, Swden.

View Article
April 2010

[New guidelines for vancomycin in staphylococcal infections].

Lakartidningen 2010 Mar 17-23;107(11):742

Klinisk mikrobiologi, Karolinska universitetssjukhuset, Solna.

View Article
April 2010

[Time to abandon "the house wine". Stop for uncritical empiric use of cefuroxime].

Lakartidningen 2009 Jan 28-Feb 3;106(5):291-2

Universitetssjukhuset Linköping.

View Article
March 2009

Lactobacillus plantarum 299v enhances the concentrations of fecal short-chain fatty acids in patients with recurrent clostridium difficile-associated diarrhea.

Dig Dis Sci 2007 Sep 10;52(9):2082-6. Epub 2007 Apr 10.

Infectious Diseases Research Unit, Department of Clinical Sciences, Lund University, 20502 Malmö, Sweden.

View Article
September 2007

Pharmacodynamic studies of vancomycin, metronidazole and fusidic acid against Clostridium difficile.

Chemotherapy 2007 25;53(4):267-74. Epub 2007 Jun 25.

Infectious Diseases Research Unit, Department of Clinical Sciences, Malmö, Sweden.

View Article
September 2007

Pharmacodynamic effects of telavancin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains in the presence of human albumin or serum and in an in vitro kinetic model.

Antimicrob Agents Chemother 2007 Sep 9;51(9):3311-6. Epub 2007 Jul 9.

Infectious Diseases Unit, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.

View Article
September 2007

Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.

J Antimicrob Chemother 2006 Nov 26;58(5):960-5. Epub 2006 Aug 26.

Infectious Diseases Research Unit, Department of Clinical Sciences, Malmö, Lunds University S-20502 Malmö, Sweden.

View Article
November 2006

[Treatment of patients with skin and soft tissue infections. Results from the STRAMA survey of diagnoses and prescriptions among general practitioners].

Lakartidningen 2006 Oct 18-24;103(42):3165-7

Britsarvets vårdcentral, Falun och Centrum för klinisk forskning.

View Article
November 2006

Pharmacodynamic studies of amoxicillin against Streptococcus pneumoniae: comparison of a new pharmacokinetically enhanced formulation (2000 mg twice daily) with standard dosage regimens.

J Antimicrob Chemother 2004 Dec 24;54(6):1062-6. Epub 2004 Nov 24.

Antibiotic Research Unit, Department of Medical Sciences, Infectious Diseases and Clinical Bacteriology, Uppsala University, 20502 Malmö, Sweden.

View Article
December 2004

A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea.

J Antimicrob Chemother 2004 Jul 26;54(1):211-6. Epub 2004 May 26.

Department of Infectious Diseases, University Hospital, Malmö, Sweden.

View Article
July 2004

The use of CRP tests in patients with respiratory tract infections in primary care in Sweden can be questioned.

Scand J Infect Dis 2004 ;36(3):192-7

Centre for Clinical Research, Nissers väg 3, Falun, Sweden.

View Article
June 2004

Management of urinary tract infections in primary care: a repeated 1-week diagnosis-prescribing study in five counties in Sweden in 2000 and 2002.

Scand J Infect Dis 2004 ;36(2):134-8

Centre for Clinical Research, Dalarna and Primary Care, Division of Medicine and Care, Faculty of Health Sciences, Linköping, Sweden.

View Article
May 2004

Perception of risk factors for infusion phlebitis among Swedish nurses: a questionnaire study.

J Infus Nurs 2004 Jan-Feb;27(1):25-30

Department of Infectious Diseases at Malmö University Hospital, Sweden.

View Article
March 2004

Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cells: a possible factor in the pathogenesis of infusion phlebitis.

J Antimicrob Chemother 2004 Feb 16;53(2):174-9. Epub 2004 Jan 16.

Departments of Infectious Diseases and Medical Microbiology, Malmö University Hospital, Lund University, SE 205 02 Malmö, Sweden.

View Article
February 2004

Postantibiotic and sub-MIC effects of benzylpenicillin against Streptococcus pneumoniae with different susceptibilities for penicillin.

Chemotherapy 2003 Dec;49(6):287-93

Antibiotic Research Unit, Department of Infectious Diseases and Clinical Microbiology, University Hospital, Uppsala, Sweden.

View Article
December 2003

Postantibiotic, postantibiotic sub-MIC, and subinhibitory effects of PGE-9509924, ciprofloxacin, and levofloxacin.

Antimicrob Agents Chemother 2003 Oct;47(10):3352-6

Antibiotic Research Unit, Department of Infectious Diseases and Clinical Microbiology, University Hospital, Uppsala, Sweden.

View Article
October 2003

Activity of three disinfectants and acidified nitrite against Clostridium difficile spores.

Infect Control Hosp Epidemiol 2003 Oct;24(10):765-8

Department of Infectious Diseases, Lund University, Malmö University Hospital, Malmö, Sweden.

View Article
October 2003

Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial.

Scand J Infect Dis 2003 ;35(6-7):365-7

Department of Infectious Diseases, University Hospital Malmö, Malmö, Sweden.

View Article
September 2003

Dicloxacillin: a higher risk than cloxacillin for infusion phlebitis.

Scand J Infect Dis 2003 ;35(6-7):397-400

Department of Infectious Diseases, Lund University, Malmö University Hospital, Malmö, Sweden.

View Article
September 2003

Variation in the propensity to release endotoxin after cefuroxime exposure in different gram-negative bacteria: uniform and dose-dependent reduction by the addition of tobramycin.

Scand J Infect Dis 2003 ;35(1):40-6

Department of Medical Sciences, Section of Infectious Diseases, Antibiotic Research Unit, Uppsala University, Uppsala, Sweden.

View Article
May 2003

Suboptimal antibiotic dosage as a risk factor for selection of penicillin-resistant Streptococcus pneumoniae: in vitro kinetic model.

Antimicrob Agents Chemother 2003 Feb;47(2):518-23

Antibiotic Research Unit, Department of Infectious Diseases and Clinical Bacteriology, University Hospital, Uppsala, Sweden.

View Article
February 2003

Antibiotics differ in their tendency to cause infusion phlebitis: a prospective observational study.

Scand J Infect Dis 2002 ;34(7):512-9

Department of Infectious Diseases, Malmö University Hospital, Lund University, Malmö, Sweden.

View Article
January 2003

Pharmacodynamics of moxifloxacin against Streptococcus pyogenes in an in vitro kinetic model.

Antimicrob Agents Chemother 2002 Jun;46(6):2046-8

Antibiotic Research Unit, Department of Infectious Diseases and Clinical Microbiology, University Hospital, Uppsala, Sweden.

View Article
June 2002

[Many travellers suffer of side-effects of malaria prophylaxis].

Lakartidningen 2002 Jun;99(26-27):2939-44

Kirurgkliniken, Ornsköldsviks sjukhus.

View Article
June 2002

Bactericidal effects of levofloxacin in comparison with those of ciprofloxacin and sparfloxacin.

Clin Microbiol Infect 1998 May;4(5):264-270

Antibiotic Research Unit, Department of Infectious Diseases and Clinical Microbiology, University Hospital, Uppsala, Sweden.

View Article
May 1998

Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria.

Clin Microbiol Infect 1997 Feb;3(1):73-81

Antibiotic Research Unit, Department of Infectious Diseases and Clinical Microbiology, University Hospital, Uppsala, Sweden.

View Article
February 1997